HLF Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.25B

+3.38%

0.477

+32.4%

1.26B

+3.33%

0.674

+14.18%

1.30B

+3.42%

0.774

+31.23%

Estimates Revision

The market is revising Upward the revenue expectations for Herbalife Ltd. (HLF) for FY2025, with the revenue forecasts being adjusted by 0.17% over the past three months. During the same period, the stock price has changed by 62.64%.

Revenue Estimates for FY2025

Revise Upward

+0.17%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.68%

In Past 3 Month

Stock Price

Go Up

+62.64%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast HLF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

Current: 0.000

Low

10.00

Averages

10.00

High

10.00

Current: 0.000

Low

10.00

Averages

10.00

High

10.00

Mizuho

Neutral

maintain

$11 -> $13

2026-01-08

New

Reason

Mizuho

Price Target

$11 -> $13

2026-01-08

New

maintain

Neutral

Reason

Mizuho raised the firm's price target on Herbalife to $13 from $11 and keeps a Neutral rating on the shares. The firm adjusted targets in the food producers space as part of its 2026 outlook. Healthy living growth should outperform in 2026, but concerns for competition have compressed valuations, the analyst tells investors in a research note. Mizuho believes weak fundamentals and elevated macro uncertainty "suggest limited prospects for a broad valuation recovery."

Maxim

Anthony Vendetti

Buy

initiated

$20

2026-01-06

New

Reason

Maxim

Anthony Vendetti

Price Target

$20

2026-01-06

New

initiated

Buy

Reason

Maxim analyst Anthony Vendetti initiated coverage of Herbalife with a Buy rating and $20 price target. A turnaround is underway, enabling Herbalife to solidify its status as a leading provider of health and wellness products, the analyst tells investors in a research note. Maxim believes the U.S. regulatory concerns are resolved, and the resulting changes, including closer alignment of distributor compensation with sales to end users, have established a more sustainable business model.

Cormark

Buy

Speculative Buy

downgrade

$24

2026-01-05

New

Reason

Cormark

Price Target

$24

2026-01-05

New

downgrade

Buy

Speculative Buy

Reason

Cormark downgraded High Liner Foods to Speculative Buy from Buy with a C$24 price target.

BofA

Underperform

maintain

$7 -> $8

2025-12-19

Reason

BofA

Price Target

$7 -> $8

2025-12-19

maintain

Underperform

Reason

BofA raised the firm's price target on Herbalife to $8 from $7 and keeps an Underperform rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption growth and valuations remain dispersed across the group, but "there feels little to get them off the sidelines in '26 until fundamentals signal a greater turning of the tide," the analyst tells investors in a year-ahead note for the consumer staples group.

Citi

Buy

maintain

$11 -> $17

2025-12-12

Reason

Citi

Price Target

$11 -> $17

2025-12-12

maintain

Buy

Reason

Citi raised the firm's price target on Herbalife to $17 from $11 and keeps a Buy rating on the shares after meeting with management. The firm believes Herbalife is building a "flywheel" amid strong distributor enthusiasm. Citi now has increased confidence that the company can hit its target for sales growth in 2026.

Mizuho

John Baumgartner

Neutral

maintain

$10 -> $11

2025-11-26

Reason

Mizuho

John Baumgartner

Price Target

$10 -> $11

2025-11-26

maintain

Neutral

Reason

Mizuho analyst John Baumgartner raised the firm's price target on Herbalife to $11 from $10 and keeps a Neutral rating on the shares. The firm believes the company's fundamentals remain on a "recovery path." Herbalife's evolution under new CEO Stephan Gratziani is "increasingly encouraging," the analyst tells investors in a research note. Mizuho says a return to corporate volume growth is possible in fiscal 2026. It upped estimates for Herbalife.

Valuation Metrics

The current forward P/E ratio for Herbalife Ltd (HLF.N) is 4.84, compared to its 5-year average forward P/E of 6.76. For a more detailed relative valuation and DCF analysis to assess Herbalife Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

6.76

Current PE

4.84

Overvalued PE

9.36

Undervalued PE

4.15

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

6.37

Current EV/EBITDA

4.77

Overvalued EV/EBITDA

7.91

Undervalued EV/EBITDA

4.82

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.41

Current PS

0.26

Overvalued PS

0.69

Undervalued PS

0.13

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HLF News & Events

Events Timeline

No data

News

5.0

01-08PRnewswire

High Liner Foods Launches New Fully Cooked Frozen Seafood Line

8.0

2025-12-30NASDAQ.COM

Herbalife Ltd (HLF) Options Volume Hits 10,917 Contracts, Significantly Above Average

8.0

2025-12-18NASDAQ.COM

Herbalife (HLF) Offers August 2026 Options

People Also Watch

Frequently Asked Questions

What is Herbalife Ltd (HLF) stock price today?

The current price of HLF is 14.67 USD — it has increased 3.02 % in the last trading day.

What is Herbalife Ltd (HLF)'s business?

Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The Company has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.

What is the price predicton of HLF Stock?

What is Herbalife Ltd (HLF)'s revenue for the last quarter?

Herbalife Ltd revenue for the last quarter amounts to 1.27B USD, increased 2.69 % YoY.

What is Herbalife Ltd (HLF)'s earnings per share (EPS) for the last quarter?

Herbalife Ltd. EPS for the last quarter amounts to 0.42 USD, decreased -10.64 % YoY.

What changes have occurred in the market's expectations for Herbalife Ltd (HLF)'s fundamentals?

How many employees does Herbalife Ltd (HLF). have?

Herbalife Ltd (HLF) has 8600 emplpoyees as of January 09 2026.

What is Herbalife Ltd (HLF) market cap?

Today HLF has the market capitalization of 1.52B USD.